Gastric intestinal metaplasia in the United States: addressing the elephant in the room.
暂无分享,去创建一个
[1] M. Yeh,et al. Prevalence, Risk Factors, and Surveillance Patterns for Gastric Intestinal Metaplasia Among Patients Undergoing Upper Endoscopy with Biopsy. , 2019, Gastrointestinal endoscopy.
[2] M. Kahaleh,et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. , 2018, Gastroenterology.
[3] L. Jandorf,et al. Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk , 2017, Gut and liver.
[4] Joo Ha Hwang,et al. Screening and surveillance for gastric cancer in the United States: Is it needed? , 2016, Gastrointestinal endoscopy.
[5] A. Hölscher,et al. Treatment of early gastric cancer in the Western World. , 2014, World journal of gastroenterology.
[6] S. Menon,et al. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis , 2014, Endoscopy International Open.
[7] M. Hartman,et al. Mo1579 Duration of Endoscopic Examination Significantly Impacts Detection Rates of Neoplastic Lesions During Diagnostic Upper Endoscopy , 2011 .
[8] H. Katai,et al. The management of early gastric cancer. , 2000, Surgical oncology.